-transparent.png){kind=logo}
Raised serum alpha-fetoprotein levels measured by radioimmunoassay were found in 19 out of 24 (79%) patients with primary liver cancer and in 32 out of 311 (10%) patients with other liver diseases. The rise was transient in cases of hepatitis and a transient rise was also seen after alcohol intake ceased in two patients with cirrhosis. alpha-Fetoprotein levels exceeding 500 ng/ml were 30-50 times more common in primary liver cancer than in other liver diseases. A rise in level seems to reflect the extent of liver regeneration in liver diseases other than primary cancer.
Related Publications
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1974,
Tumori,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1976,
Indian journal of pathology & microbiology,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
May 1978,
Gastroenterology,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1983,
Acta medica Hungarica,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1970,
Lancet (London, England),
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1970,
Lancet (London, England),
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1984,
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
January 1978,
Gastroenterologie clinique et biologique,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
March 1993,
Revista clinica espanola,
E Ruoslahti, and
M Salaspuro, and
H Pihko, and
L Andersson, and
M Seppälä
September 2013,
European review for medical and pharmacological sciences,
